NuCana PLC (NCNA)
1.42
+0.09
(+6.77%)
USD |
NASDAQ |
Dec 27, 16:00
1.47
+0.05
(+3.52%)
After-Hours: 20:00
NuCana Cash from Investing (Quarterly): 0.025M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | -- |
| TC BioPharm (Holdings) PLC | -0.0379M |
| Adaptimmune Therapeutics PLC | -66.02M |
| Mereo BioPharma Group PLC | 0.00 |
| DBV Technologies SA | -0.109M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.269M |
| Cash from Financing (Quarterly) | 6.137M |
| Free Cash Flow | -15.12M |
| Free Cash Flow Per Share (Quarterly) | -2.631 |
| Free Cash Flow Yield | -476.4% |